Current calls, week 24, 2024
Tips from KI Grants Office regarding current calls
Swedish and Nordic calls
Reseanslag - Stiftelsen för Internationellt Vetenskapligt Samarbete kring Blodsjukdomar och Transplantation (SIVSBT)
SIVSBT utlyser reseanslag med inriktning mot blodsjukdomar och transplantation. Kostnader för resa och uppehälle upp till 50.000 kronor kan sökas. Resor för doktorander och nyligen disputerade kliniska forskare vid Karolinska Institutet prioriteras. Resan skall innebära besök vid konferens med egen presentation (poster eller föredrag) eller vistelse i annat laboratorium/klinik utanför Sverige för att lära nytt till gagn för det egna projektet.
Closing date: June 30, 2024
Skicka ansökan via e-mejl till: Per Ljungman, Stiftelsen för Internationellt Vetenskapligt Samarbete kring Blodsjukdomar och Transplantation, Ljungman@ki.se
Bidrag för planering av klinisk studie inom behandlingsforskning - Vetenskapsrådet
Syftet med bidraget är att skapa möjlighet för en konstellation av forskare inom akademin och hälso- och sjukvården att planera med andra aktörer inför en framtida ansökan om bidrag till klinisk studie inom behandlingsforskning. Medverkande forskare: Minst 3 och upp till 10 andra forskare ska bjudas in att medverka i ansökan. Bidragstid är 1 till 2 år. Bidragsbelopp: 400 000 - 1 200 000 kronor per år.
Closing date: August 20, 2024
Travel grants – the Royal Physiographic Society in Lund
Travel grants for junior researchers are intended for participation in conferences and workshops, for fieldwork and for research collaborations at another institution, preferably outside the Nordic region. Grants are awarded at a standard flat rate depending on the destination of the applicant. Current application is for travel in the period September 1 - November 25, 2024.
Closing date: August 26, 2024
Visiting researcher grants – Swedish Research Council for Health, Working Life and Welfare (FORTE)
Aims to contribute to development and learning and promote knowledge exchange from the international research community to Swedish research within Forte’s focus areas. The grant primarily supports shorter stays for research collaboration, exchange of experience, and learning. Grants are available for both incoming and outgoing visiting researchers. The stay should be a minimum of one month and can be maximum of six months, but the project period can be up to one year. The maximum funding amount that can be applied for is SEK 500 000.
Closing date: August 28, 2024
BioInnovation Hypotesprövning Steg 1 2024 – Vinnova
Stödjer nyskapande, mindre forsknings- och innovationsprojekt som behandlar en radikal och innovativ frågeställning. Medel kan sökas för projekt som syftar till att verifiera, bekräfta eller avfärda nydanande innovativa uppslag för ett mer omfattande projekt. Sökes i första hand av tillverkare, leverantörer och användare av biobaserade material, produkter och tjänster, men även universitet, högskolor, forskningsinstitut och andra relevanta aktörer. Finansieras med högst 500 000 kronor för ett projekt. Projekt ska samfinansieras av medverkande företag med motsvarande summa som det sökta bidraget.
Closing date: September 3, 2024
Research proposal preparation - Nordic research consortia for EU calls on antimicrobial resistance (AMR)
Projects funded under this call should form Nordic research consortia that prepare successful proposals to the calls from the EU funded One Health AMR partnership (The Horizon Europe Candidate Partnership: One Health AMR – JPIAMR), and/or from the European Partnership on Animal Health and Welfare Projects (eupahw.eu), and/or other relevant European initiatives on Antibiotic resistance. Proposals to other EU funds and/or other international tenders on One Health AMR will also be highly relevant.
Closing date: September 19, 2024
Knowledge Sharing and Capacity Building networks to strengthen Indigenous perspectives in research - NordForsk and Nordic Council of Ministers (NCM)
NordForsk announces funding for two to four Nordic knowledge-sharing and capacity-building networks for researchers working with research relevant to Indigenous peoples and/or Indigenous research. The overall aim for the call is to in the long term contribute to sustainable and ethically sound development of communities and areas where Indigenous peoples have interests, and thus contribute to maintaining trust and unity in the Nordic region. Networks funded under this call can embrace all relevant themes, subjects, subject areas and disciplines of research. The amount of funding available to Nordic partners in a network is up to NOK 1 million. Funded networks shall have a duration of two years.
Closing date: September 24, 2024
Research grants - the Nilsson-Ehle Endowments and the Royal Physiographic Society in Lund
The Nilsson-Ehle Endowments announce support to theoretical and applied research in Genetics. Grants are awarded for the studies of the structure, function and evolution of the genetic material or its practical use. The applicants may be researchers of any level starting from PhD students, but with at least two years of documented research experience in Genetics. Applications from Ph.D. students must be accompanied by a letter of recommendation from the supervisor. Researchers who have completed their Ph.D. can also apply for travel grants from the Nilsson-Ehle Travel Fund.
Closing date: September 25, 2024
Forskningsprojekt - Njurförbundet
Njurfonden utdelar bidrag för vetenskaplig forskning om njursjukdomar och njurtransplantation. Projektet ska avse medicinsk och vårdvetenskaplig forskning om njursjukdomar och njurtransplantation. Njurfonden ger inte stöd till forskning kring cancersjukdomar i njurar och urinvägar. Forskningsprojektets betydelse ur njurmedicinsk, alternativt transplantationsrelaterad, synvinkel med särskild hänsyn till klinisk betydelse inom överskådlig tid, samt patientnytta utgör viktiga prioriteringsgrunder. Varje ansökningsomgång avser ett års projekttid, bidrag till samma projekt ges vid högst tre utdelningstillfällen.
Closing date: September 30, 2024
Forskningsprojekt - Riksförbundet HjärtLung
Stödjer forskning som ökar livskvaliteten för människor som lever med hjärt-, kärl- och lungsjukdom. Prioriterade forskningsområden kopplade till hjärt-, kärl- och lungsjukdom är rehabilitering, förebyggande av återfall och försämring, egenvård, livsstil, psykisk hälsa och mötet med vården.
Closing date: September 30, 2024
NOBEL SYMPOSIA 2026
The Royal Swedish Academy of Sciences invites Swedish researchers to propose topics for the NOBEL SYMPOSIA 2026 in Physics, Chemistry, Physiology or Medicine, Literature and Economic Sciences.
The NOBEL SYMPOSIA presents an opportunity for Swedish researchers to organise international conferences at the highest scientific level, bringing them in direct contact with the international research frontier. Since the start in 1965, more than 190 NOBEL SYMPOSIA have been held.
The Programme Committee of the Nobel Foundation is the body that formally approves applications to arrange NOBEL SYMPOSIA. The Royal Swedish Academy of Sciences receives and coordinates the evaluation of proposals for NOBEL SYMPOSIA in Physics, Chemistry, Physiology or Medicine, Literature and Economic Sciences.
The Academy thus invites the Swedish academic community to propose topics for the NOBEL SYMPOSIA 2026. Through major grants from the Knut and Alice Wallenberg Foundation it is now possible to arrange one symposium per year in each of these five fields.
Applications are to be submitted no later than 11 October, 2024.
Further information and application
Inbjudan att nominera till Hilda och Alfred Erikssons pris år 2025
Kungl. Vetenskapsakademien inbjuder till nominering för Hilda och Alfred Erikssons pris senast den 1 oktober 2024 inkomma med signerat skriftligt motiverat förslag.
Vänligen se bifogat för inbjudan och nomineringsblankett.
SRP Diabetes can now offer a travel grant for those selected for a presentation (oral presentation or poster) at either EASD or ADA 2024!
Travel grant for presenting at EASD 2024 (fixed amount): 10 000 SEK
Travel grant for presenting at ADA 2024 (fixed amount): 15 000 SEK
Application period is from now until August 31!
All information on how to apply is in the attached application template which also should be used for your application.
European calls
ERC Advanced Grants 2024 – European Research Council
The ERC Advanced Grants (AdG) 2024 call is now open. An ERC AdG supports an established, leading PI who wants long-term funding to pursue a ground-breaking, ambitious project. Applicants are expected to be active researchers who have a track-record of significant research achievements and are exceptional leaders in terms of originality and significance of their research contributions.
Applications can be made in any field of research -- the ERC's grants operate on a 'bottom-up' basis without predetermined priorities.
An AdG is worth up to € 2.5 million for a period of 5 years, though an additional € 1 million can be made available.
If you’re considering applying for an ERC AdG with KI as host institution, please email tamsin.lindstrom@ki.se for more information.
Deadline: August 29, 2024
Lupus research grants -- Lupus UK
Applications should focus on the following:
• Smaller pilot studies, which will lead to applications to major funders for large-scale research trials.
• Enabling grants for basic science support, which would enable larger projects by providing essential data for large grant applications.
• Medical meetings, which would facilitate improvements to the understanding of the causes, prevention and treatment of lupus, and its research.
At present, the cap for individual applications is set at £25,000. However, this is under review and an announcement confirming the cap for this round will be made in late-spring 2024.
Deadline: 30 Aug 2024
International networks of excellence in cardiovascular and neurovascular research -- Leducq Foundation
This supports collaborative basic, translational and clinical research coordinated by centres in North America and Europe in the fields of cardiovascular and neurovascular disease.
Each application must involve coordinators from different continents. Investigators worldwide may participate in the network, if they are affiliated with an academic research centre. A network should have a minimum of three institutional members and a maximum of six.
Grants are worth up to USD 8 million over five years each.
Deadline: Letter of intent due 06 Sep 2024 (anticipated); application due 14 Feb 2025 (anticipated)
International grants -- Biocodex Microbiota Foundation
These support clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, the theme is ‘transformation of bile acids by the gut microbiota: Functional implications for the host and consequences for human health’. The project should lead to new mechanistic biological insights that are relevant to human health and disease.
Purely descriptive studies are not in the scope. Either clinical or fundamental research proposals can be submitted.
The grant is worth €200,000 over one to three years.
Deadline: 30 Nov 2024
US calls
Federal Funding
CDMRP – Melanoma Research Program (MRP) - Funding Opportunity for Fiscal Year 2024 (FY24)
Award Mechanisms: Survivorship Research Award (SRA); Idea Award (IA); Melanoma Academy Scholar Award (MASA); Team Science Award (TSA); Focused Program Award - Rare Melanomas (FPA-RM)
Abstract: The U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications to the fiscal year 2024 (FY24) Melanoma Research Program (MRP). Congress initiated the MRP in 2019 to provide support for research of high potential impact and exceptional scientific merit. The vision of the MRP is to prevent melanoma initiation and progression, and reduce hardship. The mission is to support development of earlier interventions to enhance mission readiness, diminish melanoma burden, and improve quality of life for Service Members, Veterans, their Families, and the American public.
Deadline: LOI – July 29th, 2024; Full application – August 26th, 2024
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Funding Opportunity ID: PAR-23-157
Upcoming deadlines: October 9th, 2024; March 13th, 2025
Abstract: This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. Note: For basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants” please use the companion NOFO - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH)) PAR-23-282. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activity code (e.g., PA-20-183 “Research Project Grant (Parent R01 Clinical Trial Required)”).
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: PAR-22-242
Upcoming deadlines: October 5th, 2024; February 5th, 2025; June 5th, 2025
Abstract: Purpose of this funding opportunity announcement is to encourage collaborations- between life science and physical science- that: 1) apply a multidisciplinary bioengineering approach to solve biomedical problems; and 2) develop, integrate, optimize, validate, translate or accelerate adoption of promising tools, methods and techniques: a) that fulfill an unmet need and address specific research or clinical problem in basic, translational, and/or clinical science and practice, b) capable of enhancing our understanding of health and disease, and/or c) improve practice of medicine. Applications may propose design-directed, developmental, discovery-driven, or hypothesis-driven research, and this FOA is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
Funding Opportunity ID: PAR-22-094
Upcoming deadlines: November 12th, 2024
Abstract: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease (AD) and its related dementias (ADRD) that need additional preliminary data with broader dissemination to establish them for more general use in this research field. The priority topics will be announced through a series of Notices published subsequent to this FOA.
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-MH-24-280
Upcoming deadlines: February 7th, 2025; October 7th, 2025
Abstract: The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage research that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged
Foundation
Ehlers-Danlos Society, US – Pathophysiological and Therapeutic Markers
Upcoming deadlines: Full application – 20th July, 2024
Amount: $300,000. Each grant is intended to cover expenses up to $300,000. The Indirect Cost percentage allowed for this study is 5%.
Eligibility: Open to all.
Abstract: The Pathophysiological and Therapeutic Markers RFP Grant Round aims to advance the understanding of pathophysiology and the utilization of biological markers in hypermobility spectrum disorders (HSD) and the Ehlers-Danlos syndromes (EDS). This initiative seeks to address critical issues by encouraging multidisciplinary teams to investigate specific patient populations and underlying biological mechanisms, fostering collaboration for the benefit of affected communities. Clear criteria and study designs are vital for this research round.
BrightFocus, US – Alzheimer's Disease Research Program
Upcoming deadlines: LOI – 2nd August, 2024; Full application (by invitation) – 20th December, 2024
Abstract: BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer's disease. BrightFocus is committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges. We strongly encourage applications from individuals who are from groups underrepresented in the field of Alzheimer’s disease research. The ADR program offers two types of awards:
Standard Awards: The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies. Award Amount: $300,000. Duration: 3 years.
Postdoctoral Fellowship Awards: Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant's own independent research career. Award Amount: $200,000. Duration: 2 years. Eligibility: Must be within 5 years of degree conferral.
March of Dimes Foundation, US – Discovery Research Grants
Upcoming deadlines: Full application – 6th September, 2024
Amount: $200,000. The grants are $200,000 over two years inclusive of 10% indirect costs.
Eligibility: March of Dimes invites submissions from: Health professionals, health researchers, epidemiologists, and social scientists with doctoral academic degrees and either a faculty appointment or equivalent at academic universities, hospitals, and research institutions. Applicants may not hold any other current March of Dimes grants when applying.
Abstract: Discovery Grants are for established scientists with a long history of published work in the maternal fetal health and related fields. Simply put, Discovery Grants are funding vehicles for research inquiries that are as practical as they are ambitious, as attainable as they are groundbreaking, and as transformative as they are necessary. These grants are given to researchers with inquiries that have the power to drastically reshape outcomes for families across the US and strike a decisive blow against the maternal and infant health crisis. The proposed research should focus on one of these priority topic areas: Spontaneous preterm birth; Racial inequities as they relate to morbidity, mortality, and access to care; or Cardiovascular health conditions developed during pregnancy or exacerbated during pregnancy.
Myotonic Dystrophy Foundation (MDF), US – Early Career Research Grant
Upcoming deadlines: Full application – 13th September, 2024
Amount: $190,000. $95,000 per year for two years. Indirect costs are not covered by this grant.
Eligibility: The submitting principal investigator must hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science, or equivalent degree. The terminal degree must have been received no more than ten years prior to the time of the award*. If you have completed both residency and a Ph.D., your eligibility is based on when you completed residency, and you must have completed your residency no more than ten years prior to the time of the award*. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency. *Exceptions to the ten-year limit include any periods of family or medical leave.
Abstract: Through this Request for Applications (RFA), the Myotonic Dystrophy Foundation (MDF) recognizes a need to retain early career scholars in the field of myotonic dystrophy (DM). MDF intends to issue up to two two-year awards for projects that focus on basic, translational, and/or clinical research or care projects in myotonic dystrophy. By funding projects on basic, translational, and/or clinical research or care in myotonic dystrophy, the MDF seeks to retain early-career scholars who are passionate about researching in the DM field.